News

Pico IV and iCRYO Join Forces to Transform CBD Wellness Services

Pico IV and iCRYO Join Forces to Transform CBD Wellness Services

Pico IV and iCRYO Partner to Innovate CBD IV Infusions

This exciting partnership marks a significant advancement in the acceptance of CBD within the wellness and healthcare sectors. Pico IV, known for its cutting-edge CBD-infused hydration therapies, has teamed up with iCRYO, a rapidly expanding provider of health and wellness services, to enhance the availability of CBD treatments.

Combining Expertise for Growth

The collaboration between Pico IV and iCRYO symbolizes a transformative step for the health and wellness ecosystem. By merging Pico IV's specialization in advanced IV therapies with iCRYO's stronghold in wellness, both companies aim to fast-track the integration of CBD into general health practices.

Expanding Access to CBD Benefits

Joe Young, CEO of Pico IV, expressed his enthusiasm about the partnership, stating, "We couldn't be more excited to partner with iCRYO. This collaboration will introduce the incredible benefits of CBD to new audiences and make it more accessible than ever." This synergy is focused on delivering scientifically backed therapies that positively impact health and well-being.

Commitment to Quality and Safety

Pico IV stands out with its commitment to innovation, emphasizing thorough third-party testing of all products to ensure purity and potency. Meanwhile, iCRYO operates an extensive network of wellness centers, boasting over 50 franchise locations across the country and Canada, with even more planned for the future.

In these centers, customers will have access to a diverse array of services, including IV infusions, red light therapy, and cryotherapy, all aiming to enhance overall wellness and recovery. Thanks to this partnership, Pico IV's advanced CBD-infused hydration therapies will soon be available in select iCRYO locations, providing numerous individuals with the opportunity to explore the health benefits of CBD.

Innovative CBD IV Therapy Launch

Launched recently, Pico IV's CBD IV therapy distinguishes itself as a first-of-its-kind treatment, allowing cannabinoids to be absorbed directly into the bloodstream. This innovative method leads to increased bioavailability, delivering more effective results than traditional oral or topical CBD options. Many users have reported experiencing heightened effects, making it a compelling choice for those seeking natural therapeutic solutions.

Adding Value to Wellness Services

iCRYO's CEO Kyle Jones shared his excitement regarding the addition of CBD infusions to their service offerings, stating, "We strive to provide the best treatments that the wellness industry has to offer. We are thrilled to incorporate Pico IV's advances into our services, assisting our customers on their wellness journeys." This partnership enhances the range of options available to consumers and bolsters the credibility of CBD within the wellness domain.

The Future of CBD in Health

The collaboration between these two leaders signifies a pivotal movement towards normalizing cannabinoid-driven wellness solutions in healthcare. As consumer interest in alternative and natural treatments increases, CBD IV therapies are positioned to become a mainstream component of both medical and wellness services.

Those curious about the advantages of CBD IV therapy can discover more on PicoIV.com. The website will guide visitors in identifying nearby iCRYO locations to access these innovative treatments.

About Pico IV

Pico IV is a pioneering provider of advanced IV hydration therapies committed to enhancing overall health, facilitating recovery, and promoting performance. Their extensive range of IV therapy services caters to individuals seeking wellness support and physical recovery solutions.

About iCRYO

Headquartered in Houston, TX, iCRYO's mission is to elevate the quality of life for its guests, team members, and franchisees through affordable and professional health services. They are dedicated to setting industry standards as a global wellness brand, continually expanding their franchise opportunities and locations.

Frequently Asked Questions

What does the partnership between Pico IV and iCRYO entail?

The partnership aims to increase the availability of CBD IV infusions, combining Pico IV's advanced therapies with iCRYO's wellness centers.

What are the benefits of CBD IV therapy?

CBD IV therapy allows for direct absorption of cannabinoids, leading to enhanced effectiveness compared to traditional methods.

How many locations does iCRYO operate?

iCRYO has over 50 franchise locations in the US and Canada, with more franchise opportunities in development.

What commitment does Pico IV have regarding their products?

Pico IV is dedicated to quality and safety, ensuring rigorous third-party testing for all its products.

How can I learn more about CBD IV therapy?

You can visit PicoIV.com to find more information about CBD IV therapy and locate a participating iCRYO center.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 206

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 376

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 407

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 168

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 338

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Viatris Launches Cash Tender Offers for Outstanding Notes

Updated Category News Views 56

Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...

Continue Reading
Coke Florida Launches Joyful Holiday Caravan Across Florida

Updated Category News Views 239

Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...

Continue Reading
Nexxen to Join RBC Conference, Share Insights on Technology

Updated Category News Views 68

Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...

Continue Reading
GayVeterans.us Obtains 501(c)(3) Status to Broaden Support

Updated Category News Views 125

GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...

Continue Reading
Virbac Expands Portfolio with Acquisition of Felanorm Solution

Updated Category News Views 130

Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...

Continue Reading